Abstract
To speed up the discovery of COVID-19 disease mechanisms by X-ray images, this research developed a new diagnosis platform using a deep convolutional neural network (CNN) that is able to assist radiologists with diagnosis by distinguishing COVID-19 pneumonia from non-COVID-19 pneumonia in patients based on chest X-ray classification and analysis. Such a tool can save time in interpreting chest X-rays and increase the accuracy and thereby enhance our medical capacity for the detection and diagnosis of COVID-19. The research idea is that a set of X-ray medical lung images (which include normal, infected by bacteria, infected by virus including COVID-19) are used to train a deep CNN that can distinguish between the noise and the useful information and then uses this training to interpret new images by recognizing patterns that indicate certain diseases such as coronavirus infection in the individual images. The supervised learning method is used as the process of learning from the training dataset and can be thought of as a doctor supervising the learning process. It becomes more accurate as the number of analyzed images grows, and the average accuracy is above 95%. In this way, it imitates the training for a doctor, but the theory is that since it is capable of learning from a far larger set of images than any human, it can have the potential of being more accurate.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This article does not contain any studies with human participants performed by any of the authors. We only use the historical data and X-ray images. Patient NHI were used to join data together and were removed once data quality checks have been performed. There is no interaction with or impact on patients.
Funding Statement
The reseach is supperted by middlemore hospital, New Zealand.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Health and Disability Ethics Committees approve to use health information for research as informed consent to this use has already been obtained. Details can be found from the supplement file.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Update the contents
Data Availability
https://www.kaggle.com/paultimothymooney/chest-xray-pneumonia
